logo dark logo light logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
mobile-logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
We are Company Builders

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences.

We are Industry Veterans

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

  • Dr. Brahm Segal appointed to NextCure Scientific Advisory Board; NextCure and Roswell Park Shared Nonclinical Data on the Impact of NC410 Blockade on Neutrophil-mediated T Cell Suppression at the 24th Translational Research Cancer Centers Consortium Annua

    ...

    June 22, 2022
  • Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

    ...

    June 21, 2022
  • Arcellx Announces Closing Of Upsized Public Offering Of Common Stock And Underwriters’ Full Exercise Of Option To Purchase Additional Shares

    ...

    June 21, 2022
All news

4560 Jinke Road, Jinchuang Plaza, Building 3, 8/F, Zhangjiang Hi-tech Park, Pudong, Shanghai, 201210 P.R. China
Phone: +86 21 6163 2598 | Fax: +86 21 6163 2570 | Email: info@quancapital.com

© Quan Capital. All rights reserved. Website development